Literature DB >> 20363475

Interaction of annexin A6 with cholesterol rich membranes is pH-dependent and mediated by the sterol OH.

Magdalena M Domon1, Gladys Matar, Agnieszka Strzelecka-Kiliszek, Joanna Bandorowicz-Pikula, Slawomir Pikula, Françoise Besson.   

Abstract

Annexin A6 (AnxA6), a calcium- and membrane-binding protein, is well-known to play a role in calcium homeostasis, membrane traffic and membrane organization. It had been suggested that, despite calcium-dependent interaction with anionic phospholipids, AnxA6 displays calcium-independent cholesterol binding properties. In this study, the following questions were addressed: does AnxA6 bind preferentially to cholesterol-containing biomimetic membranes? If so, what is the molecular mechanism of the binding? To answer these questions, human recombinant AnxA6-1 isoform was prepared and used with Langmuir monolayers containing various lipids. The interactions between AnxA6 and the lipid monolayers were examined by kinetic measurements of the interfacial adsorption and Brewster angle microscopy. We focused on the pH effect on the AnxA6 binding to monolayers containing cholesterol. At acidic pH, AnxA6-1 exhibits the highest affinity to monolayers containing the highest amount of cholesterol. Replacing cholesterol by cholesteryl acetate provided evidence that the hydroxyl group of cholesterol plays a role in AnxA6-lipid interactions. In addition, the affinity of recombinant AnxA6-1 tryptophan mutant (W343F) to the air/water interface and to lipid monolayers was tested. Substitution of Trp343 modified the interfacial properties of the protein and its interactions with sterol monolayers. Our results suggest that the linker region containing Trp343 is important for the interactions between AnxA6-1 and cholesterol. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20363475     DOI: 10.1016/j.jcis.2010.03.015

Source DB:  PubMed          Journal:  J Colloid Interface Sci        ISSN: 0021-9797            Impact factor:   8.128


  11 in total

Review 1.  Annexins as organizers of cholesterol- and sphingomyelin-enriched membrane microdomains in Niemann-Pick type C disease.

Authors:  Magdalena Domon; Mehmet Nail Nasir; Gladys Matar; Slawomir Pikula; Françoise Besson; Joanna Bandorowicz-Pikula
Journal:  Cell Mol Life Sci       Date:  2011-12-13       Impact factor: 9.261

Review 2.  The divergence, actions, roles, and relatives of sodium-coupled bicarbonate transporters.

Authors:  Mark D Parker; Walter F Boron
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

3.  Evidence for annexin A6-dependent plasma membrane remodelling of lipid domains.

Authors:  Anna Alvarez-Guaita; Sandra Vilà de Muga; Dylan M Owen; David Williamson; Astrid Magenau; Ana García-Melero; Meritxell Reverter; Monira Hoque; Rose Cairns; Rhea Cornely; Francesc Tebar; Thomas Grewal; Katharina Gaus; Jesús Ayala-Sanmartín; Carlos Enrich; Carles Rentero
Journal:  Br J Pharmacol       Date:  2015-01-20       Impact factor: 8.739

4.  Role of annexin A6 in cancer.

Authors:  Houbao Qi; Shuqing Liu; Chunmei Guo; Jiasheng Wang; Frederick T Greenaway; Ming-Zhong Sun
Journal:  Oncol Lett       Date:  2015-07-15       Impact factor: 2.967

5.  ISG15 functions as an interferon-mediated antiviral effector early in the murine norovirus life cycle.

Authors:  Marisela R Rodriguez; Kristen Monte; Larissa B Thackray; Deborah J Lenschow
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

6.  Cholesterol transport from late endosomes to the Golgi regulates t-SNARE trafficking, assembly, and function.

Authors:  Meritxell Reverter; Carles Rentero; Sandra Vilà de Muga; Anna Alvarez-Guaita; Vishwaroop Mulay; Rose Cairns; Peta Wood; Katia Monastyrskaya; Albert Pol; Francesc Tebar; Joan Blasi; Thomas Grewal; Carlos Enrich
Journal:  Mol Biol Cell       Date:  2011-11       Impact factor: 4.138

7.  Reduced annexin A6 expression promotes the degradation of activated epidermal growth factor receptor and sensitizes invasive breast cancer cells to EGFR-targeted tyrosine kinase inhibitors.

Authors:  Rainelli B Koumangoye; Gladys N Nangami; Pamela D Thompson; Vincent K Agboto; Josiah Ochieng; Amos M Sakwe
Journal:  Mol Cancer       Date:  2013-12-19       Impact factor: 27.401

8.  Implication of calcium activated RasGRF2 in Annexin A6-mediated breast tumor cell growth and motility.

Authors:  Diva S Whalen; Sarrah E Widatalla; Olga Y Korolkova; Gladys S Nangami; Heather K Beasley; Stephen D Williams; Carlos Virgous; Brian D Lehmann; Josiah Ochieng; Amos M Sakwe
Journal:  Oncotarget       Date:  2019-01-04

9.  Annexin A6-balanced late endosomal cholesterol controls influenza A replication and propagation.

Authors:  Agnes Musiol; Sandra Gran; Christina Ehrhardt; Stephan Ludwig; Thomas Grewal; Volker Gerke; Ursula Rescher
Journal:  MBio       Date:  2013-11-05       Impact factor: 7.867

10.  Selective Degradation Permits a Feedback Loop Controlling Annexin A6 and Cholesterol Levels in Endolysosomes of NPC1 Mutant Cells.

Authors:  Elsa Meneses-Salas; Ana García-Melero; Patricia Blanco-Muñoz; Jaimy Jose; Marie-Sophie Brenner; Albert Lu; Francesc Tebar; Thomas Grewal; Carles Rentero; Carlos Enrich
Journal:  Cells       Date:  2020-05-07       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.